WO2004094661A3 - Genes fancc, dad1, grim19 et hadhii marquers du psoriasis - Google Patents

Genes fancc, dad1, grim19 et hadhii marquers du psoriasis Download PDF

Info

Publication number
WO2004094661A3
WO2004094661A3 PCT/FR2004/000934 FR2004000934W WO2004094661A3 WO 2004094661 A3 WO2004094661 A3 WO 2004094661A3 FR 2004000934 W FR2004000934 W FR 2004000934W WO 2004094661 A3 WO2004094661 A3 WO 2004094661A3
Authority
WO
WIPO (PCT)
Prior art keywords
hadhii
grim19
dad1
fancc
psoriasis
Prior art date
Application number
PCT/FR2004/000934
Other languages
English (en)
Other versions
WO2004094661A2 (fr
Inventor
Valerie Trinquet
Patricia Rossio
Paul Fogel
Original Assignee
Galderma Res & Dev
Valerie Trinquet
Patricia Rossio
Paul Fogel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev, Valerie Trinquet, Patricia Rossio, Paul Fogel filed Critical Galderma Res & Dev
Priority to CA002522120A priority Critical patent/CA2522120A1/fr
Priority to EP04742515A priority patent/EP1618213A2/fr
Publication of WO2004094661A2 publication Critical patent/WO2004094661A2/fr
Publication of WO2004094661A3 publication Critical patent/WO2004094661A3/fr
Priority to US11/249,305 priority patent/US20060115836A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention a pour objet l'utilisation des sondes relatives aux gènes FANCC, DAD1, GRIM19 et HADHII pour la caractérisation d'un échantillon biologique. L'invention a également pour objet l'utilisation de ces sondes pour l'identification d'un composé destiné au traitement du psoriasis, un procédé d'identification ainsi qu'un nouvel outil de recherche.
PCT/FR2004/000934 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii marquers du psoriasis WO2004094661A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002522120A CA2522120A1 (fr) 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii du psoriasis
EP04742515A EP1618213A2 (fr) 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii marqueurs du psoriasis
US11/249,305 US20060115836A1 (en) 2003-04-16 2005-10-14 Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR03/04773 2003-04-16
FR0304773A FR2853910B1 (fr) 2003-04-16 2003-04-16 Genes du psoriasis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/249,305 Continuation US20060115836A1 (en) 2003-04-16 2005-10-14 Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis

Publications (2)

Publication Number Publication Date
WO2004094661A2 WO2004094661A2 (fr) 2004-11-04
WO2004094661A3 true WO2004094661A3 (fr) 2005-10-13

Family

ID=33041917

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/000934 WO2004094661A2 (fr) 2003-04-16 2004-04-15 Genes fancc, dad1, grim19 et hadhii marquers du psoriasis

Country Status (5)

Country Link
US (1) US20060115836A1 (fr)
EP (1) EP1618213A2 (fr)
CA (1) CA2522120A1 (fr)
FR (1) FR2853910B1 (fr)
WO (1) WO2004094661A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983873B1 (fr) * 2011-12-13 2016-12-30 Oreal Marqueurs indicatifs de l'etat d'un cuir chevelu et utilisations.
KR101724169B1 (ko) * 2012-09-05 2017-04-06 가톨릭대학교 산학협력단 Ｇｒｉｍ19를 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 예방 또는 치료용 조성물
CN105861709B (zh) * 2016-05-19 2019-10-18 山东大学齐鲁医院 利用颗粒细胞grim-19相对表达量来评价卵母细胞发育潜能的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681942A (en) * 1992-04-29 1997-10-28 Hsc Research & Development Limited Partnership Fanconi Anemia Type C gene
WO1998051792A1 (fr) * 1997-05-15 1998-11-19 Brigham & Women's Hospital, Inc. Molecules fac et leurs utilisations
WO2000009754A2 (fr) * 1998-08-14 2000-02-24 Johnson & Johnson Consumer Companies, Inc. COMPOSITIONS ASSOCIEES A LA STEAROYL-CoA DESATURASE HUMAINE ET PROCEDES DE TRAITEMENT D'AFFECTIONS CUTANEES
WO2000058506A2 (fr) * 1999-03-26 2000-10-05 The University Of Leicester Depistage d'une predisposition au psoriasis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681942A (en) * 1992-04-29 1997-10-28 Hsc Research & Development Limited Partnership Fanconi Anemia Type C gene
WO1998051792A1 (fr) * 1997-05-15 1998-11-19 Brigham & Women's Hospital, Inc. Molecules fac et leurs utilisations
WO2000009754A2 (fr) * 1998-08-14 2000-02-24 Johnson & Johnson Consumer Companies, Inc. COMPOSITIONS ASSOCIEES A LA STEAROYL-CoA DESATURASE HUMAINE ET PROCEDES DE TRAITEMENT D'AFFECTIONS CUTANEES
WO2000058506A2 (fr) * 1999-03-26 2000-10-05 The University Of Leicester Depistage d'une predisposition au psoriasis

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
LEE K Y ET AL: "Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 459, no. 3, 15 October 1999 (1999-10-15), pages 323 - 326, XP004260372, ISSN: 0014-5793 *
MIELE L ET AL: "Arbiter of differentiation and death: Notch signaling meets apoptosis", JOURNAL OF CELLULAR PHYSIOLOGY, LISS, NEW YORK, NY, US, vol. 181, no. 3, 1999, pages 393 - 409, XP000907433, ISSN: 0021-9541 *
OESTREICHER J L ET AL: "Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling.", THE PHARMACOGENOMICS JOURNAL. 2001, vol. 1, no. 4, 2001, pages 272 - 287, XP008036398, ISSN: 1470-269X *
PRADET-BALADE B ET AL: "Translation control: bridging the gap between genomics and proteomics?", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 26, no. 4, 1 April 2001 (2001-04-01), pages 225 - 229, XP004233580, ISSN: 0968-0004 *
STEENS R D ET AL: "PULMONARY ALVEOLAR PROTEINOSIS IN ASSOCIATION WITH FANCONI'S ANEMIA AND PSORIASIS A POSSIBLE COMMON PATHOGENETIC MECHANISM", CHEST, vol. 102, no. 2, 1992, pages 637 - 638, XP008036482, ISSN: 0012-3692 *
THÉLU JACQUES ET AL: "Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing.", BMC DERMATOLOGY [ELECTRONIC RESOURCE]. 29 APR 2002, vol. 2, no. 1, 29 April 2002 (2002-04-29), pages 7 (1-12), XP002299238, ISSN: 1471-5945 *

Also Published As

Publication number Publication date
WO2004094661A2 (fr) 2004-11-04
CA2522120A1 (fr) 2004-11-04
EP1618213A2 (fr) 2006-01-25
FR2853910B1 (fr) 2007-08-24
FR2853910A1 (fr) 2004-10-22
US20060115836A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
AU2002322302A1 (en) Identification by analysis of physiometric variation
WO2004052175A3 (fr) Procedes pour l'identification rapide de pathogenes chez les humains et chez les animaux
AU2003902299A0 (en) A method of analysing a marker nucleic acid molecule
WO2004060278A3 (fr) Procedes d'identification rapide de pathogenes chez l'homme et les betes
AU2003286860A1 (en) Method of automatic evoked response sensing vector selection using evoked response waveform analysis
WO2003004614A3 (fr) Identification et utilisation de sequences non codantes conservees
WO2003042173A8 (fr) Antagonistes de nk1
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
WO2004094661A3 (fr) Genes fancc, dad1, grim19 et hadhii marquers du psoriasis
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
WO2007050735A8 (fr) Marqueurs de traits de production
WO2004094660A3 (fr) Gene dpysl3 comme marqueur du psoriasis
AUPS064202A0 (en) Improved method for the analysis of nucleic acid samples
ATE282721T1 (de) Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile
WO2004064783A3 (fr) Neurotoxine derivee des eosinophiles comme marqueur du cancer de l'ovaire
DE602004027086D1 (de) Klassifizierung von kolonkrebs
BRPI0413741A (pt) métodos para preparar thip e para preparar um composto, e, composto
WO2002046468A3 (fr) Procede d'analyse et/ou sequencage d'oligonucleotides mettant en oeuvre une technique maldi-tof-ms
FR2854402A1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
DE602004022857D1 (de) 2-methyl-6-solanylbenzochinon-methyltransferase als ziel für herbizide
WO2004048377A3 (fr) Procede de preparation d'inhibiteurs de phosphodiesterase-4
WO2004028447A3 (fr) Nouvelles compositions et methodes destinees au traitement du psoriasis
WO2002061074A1 (fr) Nouvelle proteine et adn la comprenant
WO2005047513A3 (fr) Complexe de la glycine decarboxylase comme cible herbicide
WO2004055200A3 (fr) Procedes de criblage de composes destines a etre utilises dans le traitement d'une maladie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004742515

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2522120

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 11249305

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2004742515

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11249305

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2004742515

Country of ref document: EP